Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA.
about
In vivo biodistribution and toxicity of intravesical administration of quantum dots for optical molecular imaging of bladder cancer.Oncological Outcomes of Sequential Intravesical Gemcitabine and Docetaxel in Patients with Non-Muscle Invasive Bladder Cancer.Can routine outpatient follow-up of patients with bladder cancer be improved? A multicenter prospective observational assessment of blue light flexible cystoscopy and fulguration
P2860
Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Hexaminolevulinate blue-light ...... on appropriate use in the USA.
@en
type
label
Hexaminolevulinate blue-light ...... on appropriate use in the USA.
@en
prefLabel
Hexaminolevulinate blue-light ...... on appropriate use in the USA.
@en
P2093
P2860
P356
P1476
Hexaminolevulinate blue-light ...... on appropriate use in the USA
@en
P2093
Anne K Schuckman
Ashish M Kamat
Badrinath R Konety
Cheryl T Lee
Gary D Steinberg
H Barton Grossman
J Alfred Witjes
Kamal S Pohar
Leonard G Gomella
Mark P Schoenberg
P2860
P2888
P304
P356
10.1038/NRUROL.2014.245
P407
P577
2014-09-23T00:00:00Z
P5875
P6179
1004325405